stockrow
Saturday 7 November 2026
Export ODTX’s income statement to Excel — free account
Odyssey Therapeutics, Inc.
ODTX Healthcare Biotechnology
19.13
0.25
+1.32%
Follow ODTX
Alert me
| Sep '26 | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
| 0.00% | 0.00% | 0.00% | — |
+3 more TTM periods Free account |
|
| 0.00% | (69.34%) | 0.00% | — | ||
ROIC |
(238.81%) | (99.09%) | (2,416.69%) | 0.00% | |
Return on Tangible Assets |
(56.77%) | (56.28%) | (90.53%) | 0.00% | |
Free Cash Flow per Share |
(3.10) | (4.65) | (25.81) | — | |
Free Cash Flow |
(148.71) | (140.89) | (145.97) | — | |
Capital Expenditures |
(0.36) | 0.17 | (0.79) | — | |
| Other line items | |||||
Cash ROIC |
(21.19%) | (19.25%) | (41.05%) | 0.00% | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.00 | 0.00 | 0.00 | — | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | — | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | — | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | — | |
Interest Coverage |
(4,422.60) | (5,315.91) | (10,607.67) | — | |
Operating CF/Net income |
0.83 | 0.84 | 0.95 | — | |
Depreciation/Fixed assets |
0.95 | 0.96 | 0.75 | 0.00 | |
Capex/Depreciation |
(0.08) | 0.04 | (0.16) | — | |
Revenue per Share |
0.00 | 0.00 | 0.00 | — | |
Operating CF per Share |
(3.09) | (4.66) | (25.67) | — | |
Capex per Share |
(0.01) | 0.01 | (0.14) | — | |
Capex to Sales |
0.00 | 0.00 | 0.00 | — |
Columns are period end dates · fundamentals updated 6 Nov 2026